Vol 13, No 6 (June 30, 2024): Translational Cancer Research

Original Article

Machine learning prediction of the case-fatality of COVID-19 and risk factors for adverse outcomes in patients with non-small cell lung cancer
Ye Ji Jung, Joonghyun Ahn, Sehhoon Park, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Sun Young Cho, Hyun Ae Jung
Translational Cancer Research  
2024;
13
(6)
:2587-2595
.
Extracellular vesicles isolated from curcumin-medium weakened RKO cell proliferation and migration
Chunyan Xu, Chengxia Liu
Translational Cancer Research  
2024;
13
(6)
:2596-2604
.
A novel inflammatory nutrient index for predicting survival outcomes in patients with non-small cell lung cancer
Tingtian Li, Qing Liu, Meng Li
Translational Cancer Research  
2024;
13
(6)
:2605-2617
.
Naringin inhibits cisplatin resistance of ovarian cancer cells by inhibiting autophagy mediated by the TGF-β2/smad2 pathway
Yi Wang, Yongsheng Wang, Chunying Yuan, Nanyi Wang, Tingsu Zhang
Translational Cancer Research  
2024;
13
(6)
:2618-2628
.
Construction and validation of a prognostic and therapeutic cuproptosis- and immune-related gene signature in hepatocellular carcinoma
Qianqian Cheng, Wei Wang, Zhenyu Lv, Wenbin Ji, Jing Liu, Xueli Zhou, Yan Yang
Translational Cancer Research  
2024;
13
(6)
:2629-2646
.
The prognostic value of immune escape-related genes in lung adenocarcinoma
Hao Ran Jia, Wen Chao Li, Lin Wu
Translational Cancer Research  
2024;
13
(6)
:2647-2661
.
Neoadjuvant therapy bridging percutaneous coronary intervention (PCI) and video-assisted thoracoscopic (VATS) lobectomy: a retrospective study
Lin Guo, Songlei Ou, Shaoyan Zhang, Dong Li, Xuchen Ma
Translational Cancer Research  
2024;
13
(6)
:2662-2673
.
Significance of dysregulated M2 macrophage and ESR2 in the ovarian metastasis of gastric cancer
Jianpeng Gao, Zhenxiong Zhao, Hongda Pan, Yakai Huang
Translational Cancer Research  
2024;
13
(6)
:2674-2690
.
Increase in GPIHBP1 expression in advanced stage colorectal cancer indicates poor immune surveillance
Min Gao, Liting Liao, Zhijie Lin, Xiangyu Hu, Linhui Jia, Weijuan Gong, Xiaoqin Jia
Translational Cancer Research  
2024;
13
(6)
:2691-2703
.
Construction of a new prognostic model for colorectal cancer based on bulk RNA-seq combined with The Cancer Genome Atlas data
Yu Ye, Gang Xu
Translational Cancer Research  
2024;
13
(6)
:2704-2720
.
Screening of postoperative adjuvant chemotherapy-related serum metabolic markers in breast cancer patients based on 1H NMR metabonomics
Ranran Hou, Wenbin Huang, Yufeng Lin, Weiping Li, Jianwei Dong, Xinping Huang, Man Xu, Qian Li, Yongcheng Zhang, Yongxia Yang
Translational Cancer Research  
2024;
13
(6)
:2721-2734
.
Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for resectable esophageal cancer: a systematic review and meta-analysis
Mingxing Wang, Wanhui Dong, Aixin Liu, Tong Lai, Baorui Zhang, Qingming Sun
Translational Cancer Research  
2024;
13
(6)
:2735-2750
.
Development and external validation of a prognostic nomogram to predict survival in patients aged ≥60 years with pancreatic ductal adenocarcinoma
Binjiao Zheng, Gangfeng Ding, Guangrong Lu, Lili Li
Translational Cancer Research  
2024;
13
(6)
:2751-2766
.
SYT7 promotes breast cancer cells growth through the PI3K/AKT pathway
Chenghao Luo, Qingfan Mo, Guosheng Ren
Translational Cancer Research  
2024;
13
(6)
:2767-2778
.
Head-to-head comparison of [68Ga]Ga-FAPI-04 PET and [18F]FDG PET in the detection of cancer recurrence: a systematic review and meta-analysis
Qinchao Wu, Chen Wang, Chao Huang, Dan Li
Translational Cancer Research  
2024;
13
(6)
:2779-2789
.
Development of a prediction model for the association between thyroid dysfunction and breast cancer
Yuehong Tang, Bilin Zhu, Xuelian Wen, Yan Chen
Translational Cancer Research  
2024;
13
(6)
:2790-2798
.
Construction of m7G RNA modification-related prognostic model and prediction of immune therapy response in hepatocellular carcinoma
Haoran Wang, Xian Shui, Zheng Zhang, Meng He, Sheng Tai, Yujia Lin
Translational Cancer Research  
2024;
13
(6)
:2799-2811
.
Overexpression of CENPU promotes cancer growth and metastasis and is associated with poor survival in patients with nasopharyngeal carcinoma
Cheng Lin, Jiani Xiong, Yuebing Chen, Huiping Zheng, Meifang Li
Translational Cancer Research  
2024;
13
(6)
:2812-2824
.
Prognostic value of GARS in bladder cancer and its role in the tumor microenvironment
Kaifei Chen, Shuaiqi Chen, Shangrong Wu, Guangyu Sun, Yuchen Jiang, Ranlu Liu
Translational Cancer Research  
2024;
13
(6)
:2825-2846
.
MFAP2 induces epithelial-mesenchymal transformation of osteosarcoma cells by activating the Notch1 pathway
Shan Jiang, Ziang Zheng, Bo Yuan, Rushan Yan, Qijun Yao, Haoran Chen, Yongxun Zhang, Yue Lei, Haidong Liang
Translational Cancer Research  
2024;
13
(6)
:2847-2859
.
Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma
Qin Zeng, Bo Chen, Wei Wang
Translational Cancer Research  
2024;
13
(6)
:2860-2876
.
Value analysis of ITLN1 in the diagnostic and prognostic assessment of colorectal cancer
Yun Zhang, Tianyuan Gao, Min Wu, Zhengyuan Xu, Huixian Hu
Translational Cancer Research  
2024;
13
(6)
:2877-2891
.
Analysis of methylation-driven genes for predicting the prognosis of patients with oral squamous cell carcinoma
Jun Chen, Zejun Dong, Biaodong Li, Zhiliang Nie, Jiaxuan Qiu
Translational Cancer Research  
2024;
13
(6)
:2892-2904
.
The risk and survival of multiple myeloma as the second primary malignancy in a single Chinese center
Xiaoli Zhao, Jiamei Ji, Yating Li, Yunqi Cui, Zhengxu Sun, Xiaoyan Qu
Translational Cancer Research  
2024;
13
(6)
:2905-2912
.
Signature identification based on immunogenic cell death-related lncRNAs to predict the prognosis and immune activity of patients with endometrial carcinoma
Yuwei Yao, Qi Zhang, Sitian Wei, Haojia Li, Ting Zhou, Qian Zhang, Jiarui Zhang, Jun Zhang, Hongbo Wang
Translational Cancer Research  
2024;
13
(6)
:2913-2937
.
A signature of four ferroptosis-related genes in laryngeal squamous cell carcinoma
Runyu Zhao, Qun Chen, Peipei Qiao, Yingying Lu, Xiaoping Chen
Translational Cancer Research  
2024;
13
(6)
:2938-2949
.
Status and development of research on clear cell carcinoma of the ovary—a visualization-based bibliometric analysis
Chao Chen, Wei Ren, Lipeng Pei, Jingli Sun, Tianmei Bai
Translational Cancer Research  
2024;
13
(6)
:2950-2970
.
Clinicopathological significance of cancer stem cell marker CD44/SOX2 in esophageal squamous cell carcinoma (ESCC) patients and construction of a nomogram to predict overall survival
Siyue Tian, Ruibin Ma, Yingmin Liu, Fei Chen, Xiaotong Huang, Qianqian Yang, Wei Nian, Zhiqin Fan
Translational Cancer Research  
2024;
13
(6)
:2971-2984
.
Bioinformatics prediction and experimental verification identify a cuproptosis-related gene signature as prognosis biomarkers of hepatocellular carcinoma
Weiwei Wang, Zhiguo He, Haowen Jia, Jiansheng Zhang, Feng Qi
Translational Cancer Research  
2024;
13
(6)
:2985-3002
.
Benefits of adjuvant chemotherapy in elderly patients with stage IB–IIIB non-small cell lung cancer: a propensity-matched analysis
Xuan Qin, Xiangzhi Xiao, Hongwei Xia, Ke Yang, Shengchao Zhang
Translational Cancer Research  
2024;
13
(6)
:3003-3015
.
Retrospective clinical study analysis of skin adverse reactions related to epidermal growth factor receptor inhibitors
Jin-Ming Qu, Si-Jian Wen, You-Kun Lin, Hua-Xiang Lu, Kun-Qian Huang, Christoffer T. Maansson, Chung-Shien Lee, Taisuke Araki
Translational Cancer Research  
2024;
13
(6)
:3016-3030
.
Synergistic action of gemcitabine and celecoxib in promoting the antitumor efficacy of anti-programmed death-1 monoclonal antibody by triggering immunogenic cell death
Xiongjie Zhu, Wenkai Zhang, Zhongjian Yu, Xia Yang, Laiqing Li, Cuicui Chen, Temirbek Djumanazarov, David Piquemal, Abrorjon A. Yusupbekov, Yanfang Zheng
Translational Cancer Research  
2024;
13
(6)
:3031-3045
.
OIP5-AS1/miR-455-3p/microfibril-associated protein 2 axis exacerbates the progression of thyroid carcinoma
Rui Huang, Hongchun Liu, Changmin Wang
Translational Cancer Research  
2024;
13
(6)
:3046-3061
.
ITGAM sustains MAPK signaling and serves as an adverse prognostic factor and therapeutic target in acute myeloid leukemia
Chang Zhou, Lu Yang, Kai Zhao, Libo Jiang
Translational Cancer Research  
2024;
13
(6)
:3062-3074
.
Combining non-invasive liquid biopsy and a methylation analysis to assess surgical risk for early esophageal cancer
Xiaole Chen, Mingyan Li, Yongliang Li, Alberto Aiolfi, Luigi Bonavina, Toni Lerut, Xiuxia Wu, Qinsheng Zhang
Translational Cancer Research  
2024;
13
(6)
:3075-3089
.

Review Article

Exosomal microRNAs in lung cancer: a narrative review
Zhe Zhang, Fengwu Lin, Wenqi Wu, Jingyuan Jiang, Chen Zhang, Dongliang Qin, Zhenan Xu
Translational Cancer Research  
2024;
13
(6)
:3090-3105
.
Overview of the interplay between m6A methylation modification and non-coding RNA and their impact on tumor cells
Zheng Dou, Xiao-Ting Ma, Mei-Na Piao, Jian-Ping Wang, Jin-Li Li
Translational Cancer Research  
2024;
13
(6)
:3106-3125
.
Ferroptosis: a promising target for fumarate hydratase-deficient tumor therapeutics literature review
Ping Cheng, Ruohan Xia, Xianwang Wang
Translational Cancer Research  
2024;
13
(6)
:3126-3141
.
Involvement of long non-coding RNA LOXL1-AS1 in the tumourigenesis and development of malignant tumours: a narrative review
Xinmeng Wang, Ruai Liu, Jinsong Li, Boyong Wang, Yaru Lin, Jiaji Zi, Min Yu, Yuanqian Pu, Wei Xiong
Translational Cancer Research  
2024;
13
(6)
:3142-3155
.
Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review
Zeyuan Qiang, Juan Wan, Xiangzheng Chen, Haichuan Wang
Translational Cancer Research  
2024;
13
(6)
:3156-3178
.

Letter to the Editor

Predicting papillary thyroid microcarcinoma in TI-RADS 3 nodules: a combined radiomics and clinical model
Zhe Hu, Zhikang Tian, Xi Wei, Yueqin Chen
Translational Cancer Research  
2024;
13
(6)
:3179-3180
.

Retraction

Retraction: inhibitory effect of lovastatin on human lung cancer cell proliferation by regulating the ERK1/2 and COX-2 pathways
Sha Liu, Ping Yang, Mingkung Wang, Shuang Zhang, Jie Wang, Tao Pan, Ping Zhou
Translational Cancer Research  
2024;
13
(6)
:3181
.